These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 18427620)

  • 21. Cytokine expression during orthotopic corneal allograft rejection in mice.
    Sano Y; Osawa H; Sotozono C; Kinoshita S
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1953-7. PubMed ID: 9727419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CCR5 chemokine receptor mediates recruitment of MHC class II-positive Langerhans cells in the mouse corneal epithelium.
    Yamagami S; Hamrah P; Miyamoto K; Miyazaki D; Dekaris I; Dawson T; Lu B; Gerard C; Dana MR
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1201-7. PubMed ID: 15790880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prognostic values of serum concentration and urinary excretion of interleukin-1 receptor antagonist and tumor necrosis factor receptors type I and II in patients with IGA nephropathy].
    Zwiech R; Kacprzyk F; Szuflet A; Nowicki M
    Pol Arch Med Wewn; 2005 Apr; 113(4):326-33. PubMed ID: 16209246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment with the interleukin-I receptor antagonist and soluble tumor necrosis factor receptor Fc fusion protein does not prevent endotoxin-induced preterm parturition in mice.
    Fidel PL; Romero R; Cutright J; Wolf N; Gomez R; Araneda H; Ramirez M; Yoon BH
    J Soc Gynecol Investig; 1997; 4(1):22-6. PubMed ID: 9051630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early expression of proinflammatory cytokines interleukin-1 and tumor necrosis factor-alpha after corneal transplantation.
    Zhu S; Dekaris I; Duncker G; Dana MR
    J Interferon Cytokine Res; 1999 Jun; 19(6):661-9. PubMed ID: 10433368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soluble cytokine receptors sTNFR I and sTNFR II, receptor antagonist IL-1ra, and anti-inflammatory cytokines IL-10 and IL-13 in the pathogenesis of systemic inflammatory response syndrome in the course of burns in children.
    Sikora JP; Kuzański W; Andrzejewska E
    Med Sci Monit; 2009 Jan; 15(1):CR26-31. PubMed ID: 19114968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of topical blockade of interleukin-1 in experimental dry eye disease.
    Okanobo A; Chauhan SK; Dastjerdi MH; Kodati S; Dana R
    Am J Ophthalmol; 2012 Jul; 154(1):63-71. PubMed ID: 22541929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The combination of tumor necrosis factor alpha blockade with interleukin-1 and interleukin-17 blockade is more effective for controlling synovial inflammation and bone resorption in an ex vivo model.
    Chabaud M; Miossec P
    Arthritis Rheum; 2001 Jun; 44(6):1293-303. PubMed ID: 11407688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in cytokine mRNA levels in experimental corneal allografts after local clodronate-liposome treatment.
    Torres PF; Slegers TP; Peek R; van Rooijen N; van der Gaag R; Kijlstra A; de Vos AF
    Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3194-201. PubMed ID: 10586942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of topical sphingosine-1-phosphate 1 receptor agonist on corneal allograft in mice.
    Jia L; Liu Y; Wang L; Zhu J; Huang Y
    Cornea; 2014 Apr; 33(4):398-404. PubMed ID: 24573171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-term azithromycin treatment promotes cornea allograft survival in the rat.
    Wacker K; Denker S; Hildebrand A; Eberwein P; Reinhard T; Schwartzkopff J
    PLoS One; 2013; 8(12):e82687. PubMed ID: 24349336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
    Seitz M; Zwicker M; Villiger PM
    J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytokine antagonists in aged subjects and their relation with cellular immunity.
    Catania A; Airaghi L; Motta P; Manfredi MG; Annoni G; Pettenati C; Brambilla F; Lipton JM
    J Gerontol A Biol Sci Med Sci; 1997 Mar; 52(2):B93-7. PubMed ID: 9060965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-interleukin-1 and anti-tumor necrosis factor-alpha synergistically inhibit adjuvant arthritis in Lewis rats.
    Feige U; Hu YL; Gasser J; Campagnuolo G; Munyakazi L; Bolon B
    Cell Mol Life Sci; 2000 Sep; 57(10):1457-70. PubMed ID: 11078023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced experimental corneal neovascularization along with aberrant angiogenic factor expression in the absence of IL-1 receptor antagonist.
    Lu P; Li L; Liu G; Zhang X; Mukaida N
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4761-8. PubMed ID: 19458323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Constitutive systemic expression of IL-1Ra or soluble TNF receptor by genetically modified hematopoietic cells suppresses LPS induction of IL-6 and IL-10.
    Doughty LA; Patrene KD; Evans CH; Boggs SS; Robbins PD
    Gene Ther; 1997 Mar; 4(3):252-7. PubMed ID: 9135739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allograft survival enhancement using doxycycline in alkali-burned mouse corneas.
    Ling S; Li W; Liu L; Zhou H; Wang T; Ye H; Liang L; Yuan J
    Acta Ophthalmol; 2013 Aug; 91(5):e369-78. PubMed ID: 23387987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of methotrexate alone or in combination with sulphasalazine on the production and circulating concentrations of cytokines and their antagonists. Longitudinal evaluation in patients with rheumatoid arthritis.
    Barrera P; Haagsma CJ; Boerbooms AM; Van Riel PL; Borm GF; Van de Putte LB; Van der Meer JW
    Br J Rheumatol; 1995 Aug; 34(8):747-55. PubMed ID: 7551660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of topical azithromycin on corneal innate immune responses.
    Sadrai Z; Hajrasouliha AR; Chauhan S; Saban DR; Dastjerdi MH; Dana R
    Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2525-31. PubMed ID: 21296809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice.
    Hori J; Isobe M; Yamagami S; Mizuochi T; Tsuru T
    Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.